TegoScience Inc.

A191420

KR7191420009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
19,430 ^KRW	+1.62%		-5.68%	+32.54%

2023	TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	CI
2023	TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Tego Science, Inc. authorizes a Buyback Plan.

March 15, 2020

The Board of Directors of Tego Science, Inc. has authorized a buyback plan on March 16, 2020.

Latest news about TegoScience Inc.

TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	23-09-18	CI
TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
TegoScience Inc.'s Equity Buyback announced on March 16, 2020, has expired.	22-03-14	CI
TegoScience Inc.'s Equity Buyback Plan Extended till September 15, 2021.	21-03-14	CI
TegoScience Inc.'s Equity Buyback Plan Extended till March 15, 2021.	20-09-14	CI
Tranche Update on TegoScience Inc.'s Equity Buyback Plan announced on March 16, 2020.	20-06-19	CI
TegoScience Inc. announces an Equity Buyback for KRW 2,000 million worth of its shares.	20-03-16	CI
Tego Science, Inc. authorizes a Buyback Plan.	20-03-15	CI
TegoScience Inc. announced that it has received KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	16-10-20	CI
TegoScience Inc. announced that it expects to receive KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	16-10-18	CI
TegoScience Inc.(KOSDAQ:A191420) added to S&P Global BMI Index	16-09-19	CI
TegoScience Inc. announced that it has received KRW 1 billion in funding	16-06-28	CI
TegoScience Inc. announced that it expects to receive KRW 1 billion in funding	16-06-26	CI
National Pension Service and a related party acquired 5.21% stake in TegoScience Inc..	15-07-08	CI
TegoScience Inc. has completed an IPO in the amount of KRW 7,191.44 million.	14-11-04	CI
TegoScience Inc. has filed an IPO in the amount of KRW 6,658 million.	14-07-10	CI

Tego Science,Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Companyâs products mainly consist of cell therapy products, and laboratory cultured skin models.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
TEGOSCIENCE INC.	+32.54%	113M
CSL LIMITED	-2.34%	90.28B
SAMSUNG BIOLOGICS CO.,LTD.	-1.97%	39.5B
BIOGEN INC.	-15.47%	31.71B
UCB	+61.28%	26.41B
BIOMARIN PHARMACEUTICAL INC.	-22.81%	14.34B
INCYTE CORPORATION	-8.82%	12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.77%	11.8B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-45.97%	10.95B
SWEDISH ORPHAN BIOVITRUM AB	+3.30%	8.85B